XML 77 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 30, 2023
Mar. 31, 2022
Mar. 31, 2021
Sep. 29, 2023
Mar. 31, 2023
Sep. 30, 2022
Oct. 01, 2021
Dec. 29, 2023
Dec. 30, 2022
Dec. 31, 2021
Jan. 01, 2021
Jan. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Maximum potential to vest       50.00%   25.00% 25.00%          
Repurchases of common stock               $ 554,870        
Exelixis 401(k) Plan                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Expenses relating to stock match               $ 13,900 $ 11,700 $ 9,500    
March 2023 Repurchase Program                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Stock repurchase program, authorized amount         $ 550,000              
Repurchases of common stock (in shares)               26,200,000        
Repurchases of common stock               $ 550,000        
January 2024 Repurchase Program | Subsequent Event                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Stock repurchase program, authorized amount                       $ 450,000
Minimum                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of months following change in control in which an employee was terminated               3 months        
Maximum                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of months following change in control in which an employee was terminated               15 months        
Stock options                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Expiration period               7 years        
Total unrecognized compensation expense               $ 9,800        
Unrecognized compensation expense weighted-average period for recognition               1 year 10 months 24 days        
Intrinsic value of options exercised               $ 16,700 36,500 76,000    
Cash received from option exercises and purchases under the ESPP               $ 20,800 $ 13,900 $ 14,800    
Stock options | Share-based Payment Arrangement, Employee                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Award vesting period               4 years        
Stock options | Share-based Payment Arrangement, Nonemployee                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Award vesting period               1 year        
Restricted stock units                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Total unrecognized compensation expense               $ 172,700        
Unrecognized compensation expense weighted-average period for recognition               2 years 6 months        
Number of awards granted (in shares)               5,028,000        
Number of awards (in shares)               11,874,000 11,294,000      
Restricted stock units | Share-based Payment Arrangement, Employee                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Award vesting period               4 years        
Restricted stock units | Share-based Payment Arrangement, Nonemployee                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Award vesting period               1 year        
TSR-Based Restricted Stock Units                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of awards granted (in shares) 800,000 1,000,000                    
Maximum potential to vest 175.00% 175.00%                    
TSR-Based Restricted Stock Units | Share-based Payment Arrangement, Tranche One                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Vesting award percentage 50.00% 50.00%                    
TSR-Based Restricted Stock Units | Share-based Payment Arrangement, Tranche Two                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Award vesting period 1 year 1 year                    
ESPP                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares available for grant (in shares)               1,700,000        
Discount rate from market value on purchase date (as a percent)               85.00%        
Discount rate from market value on offering date (as a percent)               85.00%        
Purchase period               6 months        
Common stock issued (in shares)               900,000 600,000 500,000    
Average price per share (in dollars per share)               $ 14.56 $ 16.63 $ 17.76    
Proceeds from employee stock purchase plan               $ 12,700 $ 10,100 $ 9,500    
Performance stock units                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Unrecognized compensation expense weighted-average period for recognition               1 year 3 months 18 days        
Number of awards granted (in shares)     1,000,000         0        
Maximum potential to vest     200.00%   100.00%     125.00%     200.00%  
Additional shares to be earned (in shares)     2,100,000               4,700,000  
Number of shares earned               1,000,000        
Number of awards (in shares)               3,891,000 4,964,000      
Performance stock units | Achieved                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of awards (in shares)               1,500,000        
Performance stock units | Probable                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Total unrecognized compensation expense               $ 6,000        
Performance stock units | Not Probable                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Total unrecognized compensation expense               $ 41,400        
Performance stock units | Share-based Payment Arrangement, Tranche One                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Vesting award percentage     50.00%                  
Performance stock units | Share-based Payment Arrangement, Tranche Two                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Award vesting period     1 year                  
Performance Shares, Clinical Trial Results                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of awards granted (in shares)                     2,300,000  
Amended and Restated 2017 Equity Incentive Plan                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares available for grant (in shares)               27,900,000        
Reduction in share reserve after stock option or stock appreciation award (in shares)               1        
Reduction in share reserve after all other awards (in shares)               2